about
Drug therapy for prevention of recurrent myocardial infarctionSecondary prevention following myocardial infarction: evidence from an audit in South Wales that the National Service Framework for coronary heart disease does not address all the issuesSecondary prevention in acute myocardial infarction. Data cited from two studies were inaccurate.Oral anticoagulants are effective long-term after acute myocardial infarction.Comparison of secondary prevention measures after myocardial infarction in subjects with and without diabetes mellitus.Current concepts in secondary prevention after acute myocardial infarction.Lipids, cardiovascular disease and atherosclerosis in systemic lupus erythematosus.Comparison of estimates and calculations of risk of coronary heart disease by doctors and nurses using different calculation tools in general practice: cross sectional study.Choosing a first-line drug in the management of elevated blood pressure: what is the evidence? 3: Angiotensin-converting-enzyme inhibitors.Differential associations between actual and expected GP practice prescribing rates for statins, ACE inhibitors, and beta-blockers: a cross-sectional study in EnglandEffect of drug combinations on admission for recurrent myocardial infarctionEffect of postal prompts to patients and general practitioners on the quality of primary care after a coronary event (POST): randomised controlled trial.Use of secondary prevention pharmacotherapy after first myocardial infarction in patients with diabetes mellitus.Trial is needed of ACE inhibitors plus beta blockers in survivors of myocardial infarction.
P2860
Q28165520-DC2FCBC9-9D28-42D1-A598-F8FC8BE0D1AAQ28194446-56CB37AA-3529-4696-8FBE-53284898FCF4Q31994718-FFDB2040-7FA4-4080-90BD-0198961809EEQ33651510-90830226-FAB4-4099-9AA0-B995CB429AC7Q33680458-314C2B11-B8CC-4927-8A69-34E1B751287CQ33860933-A71F62AC-E0F7-4385-B1E8-35DA3C5CB0E6Q33915449-87D6B450-3661-4E14-B6B1-26FBC4E9C17BQ33953825-C6F0A612-6386-4348-9FDB-62646B464BBDQ34010248-C376A621-0243-4277-868E-AF9E774FB02EQ35166628-305769D8-0A5E-4624-BD87-5BB032E184A6Q36025762-7AF44BA8-7D46-46C3-9B09-15034F422205Q37462206-2C690EEF-C1E8-460A-825E-482A7CCE214DQ37501367-6FCE4272-A6BA-4D02-8DE0-AB3D14DB04F3Q42758420-3A75BAD1-FDD6-42BD-986F-9FBDA2B0C248
P2860
description
1998 nî lūn-bûn
@nan
1998 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մարտին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
name
Secondary prevention in acute myocardial infarction.
@ast
Secondary prevention in acute myocardial infarction.
@en
type
label
Secondary prevention in acute myocardial infarction.
@ast
Secondary prevention in acute myocardial infarction.
@en
prefLabel
Secondary prevention in acute myocardial infarction.
@ast
Secondary prevention in acute myocardial infarction.
@en
P2860
P356
P1433
P1476
Secondary prevention in acute myocardial infarction.
@en
P2093
P2860
P304
P356
10.1136/BMJ.316.7134.838
P407
P577
1998-03-01T00:00:00Z